272
Views
0
CrossRef citations to date
0
Altmetric
Review Article

An Investigative Review for Pharmaceutical Analysis of 1,4-Dihydropyridine-3,5-Dicarboxylic Acid Derivative: Cilnidipine

ORCID Icon &
Pages 268-277 | Published online: 12 Feb 2020

References

  • Chandra, K. S.; Ramesh, G. The Fourth-Generation Calcium Channel Blocker: Cilnidipine. Indian Heart J. 2013, 65, 691–695. DOI: 10.1016/j.ihj.2013.11.001.
  • Sakata, K.; Shirotani, M.; Yoshida, H.; Nawada, R.; Obayashi, K.; Togi, K.; Miho, N. Effects of Amlodipine and Cilnidipine on Cardiac Sympathetic Nervous System and Neurohormonal Status in Essential Hypertension. Hypertension 1999, 33, 1447–1452. DOI: 10.1161/01.HYP.33.6.1447.
  • Godfraind, T. Discovery and Development of Calcium Channel Blockers. Front. Pharmacol. 2017, 8, 286. DOI: 10.3389/fphar.2017.00286.
  • Ringer, S. A Further Contribution regarding the Influence of the Different Constituents of the Blood on the Contraction of the Heart. J. Physiol. 1883, 4, 29–42. DOI: 10.1113/jphysiol.1883.sp000120.
  • Abernethy, D. R.; Schwartz, J. B. Calcium-Antagonist Drugs. N. Engl. J. Med. 1999, 341, 1447–1457. DOI: 10.1056/NEJM199911043411907.
  • Elliott, W. J.; Ram, C. V. S. Calcium Channel Blockers. J. Clin. Hypertens. 2011, 13, 687–689. DOI: 10.1111/j.1751-7176.2011.00513.x.
  • Materson, B. J. Calcium Channel Blockers: Is It Time to Split the Lump? Am. J. Hypertens. 1995, 8, 325–329. DOI: 10.1016/0895-7061(94)00247-9.
  • Yoshimoto, R.; Dohmoto, H.; Yamada, K.; Goto, A. Prolonged Inhibition of Vascular Contraction and Calcium Influx by the Novel 1, 4-Dihydropyridine Calcium Antagonist Cinaldipine (FRC-8653). Jpn. J. Pharmacol. 1991, 56, 225–229. DOI: 10.1254/jjp.56.225.
  • Zeel, T. D.; Shah, J. S.; Maheshwari, D. G. A Review on Analytical Method for Determination of Calcium Channel Blocker in Different Dosage Forms. J. Global Trends Pharm. Sci. 2015, 6, 2829–2839.
  • Buchiya, F.; Jain, V.; Raj, H. A. Review: Analytical Methods for Determination of Cilnidipine in Biological Fluid and Pharmaceutical Dosage Forms. Pharm Tutor Mag. 2014, 2, 22–29.
  • Japanese Pharmacopoeia. Cilnidipine. In Japanese Pharmacopoeia; Society of Japanese Pharmacopoeia. Tokyo, 2016; pp. 704–705.
  • Lee, J.; Lee, H.; Jang, K.; Lim, K. S.; Shin, D.; Yu, K. S. Evaluation of the Pharmacokinetic and Pharmacodynamic Drug Interactions between Cilnidipine and Valsartan, in Healthy Volunteers. Drug Des. Dev. Ther. 2014, 8, 1781–1788. DOI: 10.2147/DDDT.S68574.
  • Indian Pharmacopoeia Commission. Indian Pharmacopoeia; Indian Pharmacopoeia Commission; Ministry of Health & Family Welfare, Government of India: Ghaziabad, India, 2018, vol. 2.
  • Shen, W. Y.; Du, Y. X.; Huang, C.; Xu, Y. G. Determination of Cilnidipine and its Tablets by RP-HPLC. J. China Pharm. Univ. 2002, 33, 544–547.
  • Pawar, P.; Gandhi, S. V.; Deshpande, P. B.; Padmanabh, B.; Vanjari, S.; Shelar, S. U. Simultaneous RP-HPLC Estimation of Cilnidipine and Telmisartan in Combined Tablet Dosage Form. Pelagia Res. Libr. 2013, 4, 6–10.
  • Rupareliya, R. H.; Joshi, H. S. Stability Indicating Simultaneous Validation of Telmisartan and Cilnidipine with Forced Degradation Behavior Study by RP-HPLC in Tablet Dosage Form. ISRN Chromatogr. 2013, 2013, 1–6. DOI: 10.1155/2013/461461.
  • Safhi, M. M.; Nagaraj, M. Y. Development and Validation of a Rapid Stability Indicating Chromatographic Determination of Cilnidipine in Bulk and Dosage Form. Res. J. Pharm. Technol. 2013, 6, 296–299.
  • Sidhdhapara, M. J.; Patel, B.; Paramar, A. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Cilnidipine and Olmesartan Medoxomil in Their Combined Tablet Dosage Form. Int. J. Pharm. Biol. Sci. 2014, 4, 157–160.
  • Ghelani, N. C.; Dadhania, K.; Faldu, S. Analytical Method Development and Validation for Simultaneous Estimation of Olmesartan Medoxomil and Cilnidipine in Their Combined Pharmaceutical Dosage Form by RP-HPLC Method. Pharm Tutor Mag. 2014, 2, 142–148.
  • Mohd, I. S.; Medidi, S. Simultaneous Estimation of Telmisartan and Cilnidipine in Bulk and in Tablet Formulation using RP-HPLC. Int. J. Adv. Pharm. Sci. 2014, 5, 2142–2148.
  • Ravichandran, S.; Valliappan, K.; Ramanathan, M. Development and Validation of Chromatographic Method for the Simultaneous Estimation of Olmesartan Medoxomil, Amlodipine Besylate, Cilnidipine in Combination Tablet Dosage Form. Int. J. Pharm. Pharm. Sci. 2015, 7, 321–324.
  • Hinge, M. A.; Desai, D. K.; Chavda, R. N.; Patel, D. R.; Shing, R. D.; Patel, E. S. Analytical Method Development and Validation for Simultaneous Estimation of Cilnidipine and Metoprolol Succinate by RP-HPLC. Der. Pharm. Lett. 2015, 7, 333–340.
  • Sunitha, N.; Mariha, S. C.; Venu, A.; Rao, B. V.; Rao, B. A. Method Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Olmesartan and Cilnidipine in Bulk and Formulations. Int. J. Pharm. Res. Allied Sci. 2015, 4, 127–135.
  • Sharma, A.; Mishra, A.; Sharma, S. Stability Indicating Simultaneous Validation of Telmisartan, Cilnidipine and Chlorthalidone with Forced Degradation Behavior Study by RP-HPLC in Tablet Dosage Form. Int. J. Chem. Pharm. Sci. 2016, 7, 6–12.
  • Patel, B. D.; Chaudhary, A. B.; Parmar, P. J.; Patel, V. N. Development and Validation of Reversed Phase High Performance Liquid Chromatography Method for Simultaneous Estimation of Nebivolol HCl and Cilnidipine in Combined Tablet Dosage Form. Pharm. Biol. Eval. 2016, 3, 208–214.
  • Kachave, R. N.; Kale, M.; Wagh, R. D. Simultaneous Estimation of Cilnidipine and Valsartan by RP-HPLC in Tablet Formulation. Eurasian J. Anal. Chem. 2016, 11, 245–253. DOI: 10.12973/ejac/63221.
  • Patel, R. D.; Luhar, S. V.; Narkhede, S. B. Analytical Method Development and Validation for Simultaneous Estimation of Cilnidipine, Olmesartan and Chlorthalidone in Synthetic Mixture by RP-HPLC Method. J. Pharm. Sci. Bio-Sci. Res. 2016, 6, 308–314.
  • Pawar, V. T.; Pawar, S. V.; More, H. N.; Kulkarni, A. S.; Gaikwad, D. T. RP-HPLC Method for Simultaneous Estimation of Cilnidipine and Chlorthalidone. Rese. J. Pharm. Technol. 2017, 10, 3990–3996. DOI: 10.5958/0974-360X.2017.00724.7.
  • Dagariya, R. K.; Jat, R. K. Method Development and Validation of Irbesartan, Chlorthalidone and Cilnidipine in Their Combined Tablet Dosage Form by High Performance Liquid Chromatography. J. Drug Deliv. Ther. 2017, 7, 88–96.
  • Patel, N. D.; Mehta, R. S.; Karkhanis, V. V.; Patel, P. D.; Chavda, A. A. Development and Validation of Stability Indicating RP-HPLC Method for Simultaneous Estimation of Nebivolol Hydrochloride and Cilnidipine in Tablet Dosage Form. J. Pharm. Sci. Bio-Sci. Res. 2017, 7, 140–147.
  • Solanki, V. S.; Bishnoi, R. S.; Baghel, R.; Jain, D. RP-HPLC Method Development and Validation for Simultaneous Estimation of Cilnidipine, Atenolol and Chlorthalidone. J. Drug Deliv. Ther. 2018, 8, 78–82. DOI: 10.22270/jddt.v8i6-s.2205.
  • Shi-Gang, W. A. N. G.; Pan, G. U. Determination of Cilnidipine Related Substances by RP-HPLC. Anhui Med. Pharm. J. 2011, 15, 10.
  • Muralidharan, S.; Kumar, J. R.; Dhanaraj, S. A. Simple and Effective HPLC Method Development and Its Validation for Clindipine in Human Drug Free Plasma. Pak. J. Pharm. Sci. 2015, 28, 135–138.
  • Zhang, X.; Zhai, S.; Zhao, R.; Ouyang, J.; Li, X.; Baeyens, W. R. Determination of Cilnidipine, a New Calcium Antagonist, in Human Plasma Using High Performance Liquid Chromatography with Tandem Mass Spectrometric Detection. Anal. Chim. Acta 2007, 600, 142–146. DOI: 10.1016/j.aca.2006.11.072.
  • Lee, H. W.; Seo, J. H.; Lee, H. S.; Jeong, S. Y.; Cho, Y. W.; Lee, K. T. Development of a Liquid Chromatography/Negative-Ion Electrospray Tandem Mass Spectrometry Assay for the Determination of Cilnidipine in Human Plasma and its Application to a Bioequivalence Study. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2008, 862, 246–251. DOI: 10.1016/j.jchromb.2007.11.016.
  • Lee, K. R.; Chae, Y. J.; Lee, J. H.; Kim, D. D.; Chong, S.; Shim, C. K.; Chung, S. J. Quantification of Cilnidipine in Human Plasma by Liquid Chromatography-Mass Spectrometry. J. Liq. Chromatogr. Relat. Technol. 2012, 35, 308–320. DOI: 10.1080/10826076.2011.597078.
  • Zeng, H.; Wang, F.; Zhu, B.; Zhong, W.; Shan, W.; Wang, J. Study of the Structures of Photodegradation Impurities and Pathways of Photodegradation of Cilnidipine by Liquid Chromatography/Q‐Orbitrap Mass Spectrometry. Rapid Commun. Mass Spectrom. 2016, 30, 1771–1778. DOI: 10.1002/rcm.7657.
  • Ch, K. R.; J. V, S. K.; Goud Palusa, S. K. Isolation and Characterization of Novel Degradation Products in Cilnidipine by LC-QTOF-MS/MS, LCMS N, 2D-NMR and FTIR. New J. Chem. 2018, 42, 634–646. DOI: 10.1039/C7NJ02781H.
  • Attimarad, M.; Ahmed, K. M.; Aldhubaib, B. E.; Harsha, S. High-Performance Thin Layer Chromatography: A Powerful Analytical Technique in Pharmaceutical Drug Discovery. Pharm. Methods 2011, 2, 71–75. DOI: 10.4103/2229-4708.84436.
  • Karmalkar, H. S.; Vaidya, V. V.; Gomes, N. A.; Choukekar, M. P.; Kekare, M. B. Determination of Cilnidipine from Pharmaceutical Formulation by High Performance Thin Layer Chromatographic Method. Anal. Chem. Indian J. 2008, 7, 573–576.
  • Pawar, P.; Deshpande, P.; Gandhi, S.; Bhavani, V. High Performance Thin Layer Chromatographic Determination of Cilnidipine and Telmisartan in Combined Tablet Dosage Form. Int. Res. J. Pharm. 2012, 3, 219–222.
  • Minase, A. S.; Dole, M. N. Development and Validation of Analytical Method for Simultaneous Estimation of Cilnidipine and Olmesartan Medoxomil in Bulk and Tablet Dosage Form by HPTLC. J. Adv. Sci. Res. 2014, 5, 34–38.
  • Bhole, R. P.; Pawara, V. C.; Chitlange, S. S.; Wankhede, S. B. Development and Validation of HPTLC Method for Simultaneous Estimation of Cilnidipine and Valsartan in Bulk and Tablet Dosage Form. Int. J. Pharm. Chem. Anal. 2015, 2, 102–107.
  • Dedhiya, P. P.; Patel, C. J.; Chauhan, R. S.; Kalyankar, G. G.; Vyas, R. H.; Shah, S. A. Development and Validation of HPTLC Method for Simultaneous Estimation of Olmesartan Medoxomil and Cilnidipine in Their Combined Pharmaceutical Dosage Forms. J. Pharm. Appl. Sci. 2015, 2, 20–27.
  • Desai, D.; Vashi, N.; Dalvadi, H.; Desai, S.; Hinge, M. HPTLC Method Development and Validation of Cilnidipine and Metoprolol Succinate in Combined Dosage Form. Pharm. Methods 2016, 7, 28–34. DOI: 10.5530/phm.2016.7.5.
  • Rathod, R. H.; Patil, A. S.; Shirkhedkar, A. A. Novel NP and RP-HPTLC in Praxis for Simultaneous Estimation of Chlorthalidone and Cilnidipine in Bulk and Pharmaceutical Formulation. Anal. Chem. Lett. 2018, 8, 862–871. DOI: 10.1080/22297928.2018.1527252.
  • Chaudhari, P. P.; Bhalerao, A. V. Method Validation for Spectrophotometric Estimation of Cilnidipine. Int. J. Pharm. Pharm. Sci. 2012, 4, 96–98.
  • Haripriya, M.; Antony, N.; Jayasekhar, P. Development and Validation of UV Spectrophotometric Method for the Simultaneous Estimation of Cilnidipine and Telmisartan in Tablet Dosage Form Utilising Simultaneous Equation and Absorbance Ratio Method. Int. J. Pharm. Biol. Sci. 2013, 3, 343–348.
  • Safhi, M. M. Spectrophotometric Method for the Estimation of Cilnidipine in Bulk and Pharmaceutical Dosage Forms. Orient J. Chem. 2013, 29, 131–134. DOI: 10.13005/ojc/290123.
  • Sidhdhapara, M.; Patel, B.; Parmar, A.; Vekariya, H.; Patel, P. Development and Validation of Spectrophotometric Method for Simultaneous Determination of Cilnidipine and Olmesartan Medoximil in Tablet Dosage Form. Int. J. Pharm. Biol. Sci. 2014, 4, 97–101.
  • Soni, I. J.; Panchal, H. J. Development and Validation of Dual Wavelength UV Spectrophotometric Method for Simultaneous Estimation of Cilnidipine and Olmesartan Medoxomil in Tablet Dosage Form. Indian J. Pharm. Biol. Res. 2014, 2, 76–81.
  • Sidhdhapara, M.; Patel, B.; Parmar, A.; Vekariya, H.; Patel, P. Derivative Spectrophotometric Method for Simultaneous Determination of Cilnidipine and Olmesartan Medoximil in Tablet Dosage Form. Der Pharm Chem. 2014, 6, 175–178.
  • Ghelani, N. C.; Bhalodiya, K.; Dadhania, K.; Faldu, S. Development and Validation of Spectrophotometric Method for Simultaneous Estimation of Olmesartan Medoxomil and Cilnidipine by Simultaneous Equation Method. Pharm Tutor Mag. 2014, 2, 160–166.
  • Patel, S. N.; Hinge, M. A.; Bhanushali, V. M. Development and Validation of an UV Spectrophotometric Method for Simultaneous Determination of Cilnidipine and Chlorthalidone. J. Pharm. Res. 2015, 9, 41–45.
  • Buchiya, F. V.; Bhim, A. I.; Raj, H. A.; Jain, V. C. Simultaneous Determination of Cilnidipine and Valsartan in Synthetic Mixture Using Spectrophotometric Technique (Simultaneous Equation Method). Asian J. Pharm. Anal. 2015, 5, 21–25. DOI: 10.5958/2231-5675.2015.00004.6.
  • Hinge, M. A.; Desai, D. K.; Patel, E. S.; Singh, R.; Chavda, R.; Patel, D. Development and Validation of UV Spectrophotometric Method for Simultaneous Estimation of Cilnidipine and Metoprolol Succinate in Bulk Drugs and Combined Dosage Form. Der Pharm. Lett. 2015, 7, 299–306.
  • Jani, R. J.; Patel, S. A. Simultaneous Spectrophotometric Determination of Azilsartan Kamedoxomil and Cilnidipine in Mixture. Int. J. Res. Pharm. Pharm. Sci. 2018, 3, 86–90.
  • Shirodkar, P. Development and Validation of Absorbance Correction Method for Simultaneous Estimation of Bisoprolol Fumarate and Cilnidipine in Tablet Dosage Form. Indian Drugs 2018.
  • Jani, R. J.; Patel, S. A. Development and Validation of Spectrophotometric Method for Simultaneous Estimation of Azilsartan Kamedoxomil and Cilnidipine in Synthetic Mixture. World J. Pharm. Res. 2018, 7, 948–958.
  • Safhi, M. M. Spectrophotometric Estimation of Cilnidipine in Tablets. Br. J. Pharm. Res. 2015, 7, 451–456. DOI: 10.9734/BJPR/2015/19275.
  • Patel, A.; Panchal, A.; Patel, V.; Nagar, A. FTIR Spectroscopic Method for Quantitative Analysis of Cilnidipine in Tablet Dosage Form. Int. J. Pharm. Sci. Res. 2015, 6, 1033–1039.
  • Tan, S.; Jiang, J.; Shen, G.; Shen, G.; Yu, R. A Novel Fluorescence Probe for Cilnidipine Assay. Anal. Chim. Acta 2005, 547, 215–220. DOI: 10.1016/j.aca.2005.05.041.
  • Du, Y.; Di, B.; Chen, J.; Zheng, Z. Development of Desulfated Chondroitin Sulfate C as a Novel Chiral Selector in Capillary Electrophoresis and Enantioseparation of Cilnidipine. Chinese J. Chromatogr. 2004, 22, 382–385.
  • Jain, R.; Kumar, D. A Highly Sensitive Hybrid Film Sensor for Voltammetric Detection of Calcium Antagonist Cilnidipine. The Electrochemical Society, Oct 2013; Paper 42.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.